| Primary information |
|---|
| sequence ID | Seq_5389 |
| Peptide sequence | MIEQNTKSPLFMGKVVNPTQK |
| CancerPDF_ID | CancerPDF_ID66, CancerPDF_ID10567, |
| PMID | 16896061,21805675 |
| Protein Name | Alpha-1-antitrypsin precursor,Alpha-1-antitrypsin |
| UniprotKB Entry Name | A1AT_HUMAN,A1AT_HUMAN |
| Fluid | Serum,Urine |
| M/Z | 797.34,2390.2117 |
| Charge | 1,NA |
| Mass (in Da) | 2390.25,NA |
| fdr | NA,NA |
| Profiling Technique | MALDI-TOF,MALDI-TOF |
| Peptide Identification technique | Q/TOF MS/MS,MALDI-TOF-MS |
| Quantification Technique | NA,NA |
| Labelled/Label Free | Label Free,Label Free |
| FDR | NA,1 |
| CancerPDF_ID | CancerPDF_ID66, CancerPDF_ID10567, |
| p-Value | 1.00E-05,NA |
| Software | MASCOT,NA |
| Length | 21,21 |
| Cancer Type | Metastatic thyroid carcinomas,Muscle-invasive bladder cancer |
| Database | NCBI refseq Protein Database,SwissProt Database |
| Modification | NA,NA |
| Number of Patients | 40 metastatic thyroid carcinoma patients and 40 normal for training phase and 10 metastatic thyroid carcinoma and 10 normal individuals for independent validation,751 bladder cancer and 127 control |
| Regulation | NA,Differentially expressed between cancer vs normal samples |
| Validation | Independent validation,Mann-Whitney tests and areas under receiver-operator characteristic |
| Sensitivity | 95% on independent dataset,NA |
| Specificity | 95% on independent dataset,NA |
| Accuracy | NA,NA |
| Peptide Atlas | PeptideAtlas |
| IEDB | 439314
|